What is Polaryx Therapeutics, Inc. 's EPS (diluted)?

Polaryx Therapeutics, Inc. (PLYX) reported EPS (diluted) of -$0.05 in Q1 2026.

How has Polaryx Therapeutics, Inc. 's EPS (diluted) changed year-over-year?

Polaryx Therapeutics, Inc. 's EPS (diluted) increased by 54.5% year-over-year, from -$0.11 to -$0.05.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Polaryx Therapeutics, Inc. PLYX EPS (Diluted)

EPS (Diluted) at other companies

BioMarin PharmaceuticalsBMRN

$0.54-43.2%

Zevra Therapeutics, Inc.ZVRA

$0.60+1,100%

Eton Pharmaceuticals, Inc.ETON

$0.05+183%

XER

Xeris Biopharma Holdings, Inc.XERS

$0.01+117%

Relay Therapeutics, Inc.RLAY

-$0.41+10.9%

PVL

Palvella TherapeuticsPVLA

-$1.20-62.2%

Other financials

Income statement

See full

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

Balance sheet

See full

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Cash flow

See full

Operating cash flow-$2.1M-191%

Valuation

See full

Market cap$132.59M-87.6%

Returns & leverage

See full

Return on equity-1,209.8%—

Current ratio3.5×—

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's EPS (diluted)?: Polaryx Therapeutics, Inc. (PLYX) reported EPS (diluted) of -$0.05 in Q1 2026.
How has Polaryx Therapeutics, Inc. 's EPS (diluted) changed year-over-year?: Polaryx Therapeutics, Inc. 's EPS (diluted) increased by 54.5% year-over-year, from -$0.11 to -$0.05.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.